Blood tests as biomarkers for the diagnosis and prognosis of sudden sensorineural hearing loss in adults: a systematic review
The Journal of Laryngology & Otology · 2023
DOI: 10.1017/s0022215123000282 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Laryngology & Otology, 2023. Verfasst von A Al-Azzawi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Hearing Loss, Sudden, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Objective
Sudden sensorineural hearing loss is considered idiopathic in up to 90 per cent of cases. This study explored the role of blood tests as biomarkers for the diagnosis and prognosis of sudden sensorineural hearing loss.
Method
Two researchers filtered 34 papers into the final review. This review was pre-registered on the Prospero database and conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines.
Results
Raised inflammatory markers are almost universal in sudden sensorineural hearing loss, suggesting an inflammatory or autoimmune process. The most useful biomarkers are neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and fibrinogen level. Focused investigations should be deployed on a case-by-case basis to identify underlying metabolic, infective and autoimmune conditions.
Conclusion
A full blood count and coagulation screen (fibrinogen) is recommended in all cases of sudden sensorineural hearing loss. These are inexpensive, accessible and offer as much diagnostic and prognostic information as any other biomarker. There is emerging evidence regarding specific biomarkers for sudden sensorineural hearing loss prognosis, with heat shock protein-70, anti-endothelial cell antibody and prestin demonstrating potential; investigation of their validity through prospective, controlled research is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, University of Manchester, Manchester, UK.
- Department of Otolaryngology, Manchester Royal Infirmary, Manchester, UK.
ORCID-Profile: E Stapleton
Zitieren
APA
Al-Azzawi, A., & Stapleton, E. (2023). Blood tests as biomarkers for the diagnosis and prognosis of sudden sensorineural hearing loss in adults: a systematic review. The Journal of Laryngology & Otology. https://doi.org/10.1017/s0022215123000282
Vancouver
Al-Azzawi A, Stapleton E. Blood tests as biomarkers for the diagnosis and prognosis of sudden sensorineural hearing loss in adults: a systematic review. The Journal of Laryngology & Otology. 2023. doi:10.1017/s0022215123000282
BibTeX
@article{AlAzzawi2023,
author = {Al-Azzawi, A and Stapleton, E},
title = {Blood tests as biomarkers for the diagnosis and prognosis of sudden sensorineural hearing loss in adults: a systematic review},
journal = {The Journal of Laryngology & Otology},
year = {2023},
doi = {10.1017/s0022215123000282}
}
EUVIMED